Related Experiment Video
Updated: Jun 5, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Pathogenesis of myeloma.
Kenneth C Anderson1, Ruben D Carrasco
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Annual Review of Pathology
|January 26, 2011
Summary
Multiple myeloma (MM) is a cancer of plasma cells, marked by bone destruction and immune suppression. Research highlights genetic changes and the tumor microenvironment
Area of Science:
- Hematology
- Oncology
- Cancer Biology
Background:
- Multiple myeloma (MM) is a malignant proliferation of terminally differentiated B cells (plasma cells).
- It is characterized by bone marrow infiltration, skeletal destruction, monoclonal gammopathy, and immune suppression.
- MM develops from a precursor condition, monoclonal gammopathy of undetermined significance.
Purpose of the Study:
- To review the genomic landscape of multiple myeloma.
- To explore the role of the bone marrow microenvironment and cancer stem cells in MM.
- To understand mechanisms of therapeutic resistance in MM.
Main Methods:
- Review of recent scientific literature on multiple myeloma genomics, microenvironment interactions, and therapeutic resistance.
- Analysis of genetic aberrations, oncogene mutations, and tumor suppressor gene alterations in MM.
- Investigation of signaling pathways and myeloma cancer stem cell roles.
Main Results:
- MM genomes exhibit significant chromosomal aberrations and mutations, distinct from many hematological malignancies.
- Interactions between MM cells and the bone marrow microenvironment are crucial for tumor growth and survival.
- Dysregulation of signaling pathways and the presence of myeloma cancer stem cells contribute to treatment resistance.
Conclusions:
- Multiple myeloma pathogenesis involves complex genetic alterations and critical interactions within the bone marrow niche.
- Understanding these factors, including myeloma cancer stem cells, is essential for developing effective therapeutic strategies.
- Further research into MM biology is needed to overcome treatment resistance and improve patient outcomes.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...